Can quetiapine (Seroquel), naltrexone, bupropion (Wellbutrin), and atomoxetine (Strattera) be prescribed together in an adult patient?

Can These Medications Be Prescribed Together?

Yes, quetiapine (Seroquel), naltrexone, bupropion (Wellbutrin), and atomoxetine (Strattera) can be prescribed together in adults, but this combination requires careful monitoring for specific drug interactions and cumulative central nervous system effects.

Key Safety Considerations

Drug-Drug Interactions to Monitor

The primary concern with this combination is the cumulative CNS depressant effects when multiple psychotropic medications are used together. The 2019 AGS Beers Criteria specifically warns about concurrent use of three or more CNS agents (including antidepressants, antipsychotics, benzodiazepines, antiepileptics, and opioids) due to increased fall risk 1.

Critical monitoring points:

• Blood pressure and heart rate: Both naltrexone/bupropion and atomoxetine can increase blood pressure and heart rate 2, 3
• Seizure threshold: Bupropion lowers seizure threshold; quetiapine may also affect this 2
• Suicidality monitoring: Both bupropion and atomoxetine carry warnings for increased suicidal ideation, particularly in younger patients 3

Specific Drug Considerations

Naltrexone/Bupropion Combination:

• When used together (as in Contrave), these medications are well-studied and FDA-approved for obesity treatment 2
• Common side effects include nausea (4-32%), headache, constipation, dizziness 2
• Contraindicated with seizure disorders, uncontrolled hypertension, and within 14 days of MAOI use 2, 4

Adding Quetiapine:

• No absolute contraindication exists for combining quetiapine with naltrexone/bupropion
• One small study showed quetiapine plus naltrexone was well-tolerated in alcohol-dependent patients, though it didn't show additional benefit 5
• Monitor for additive sedation and metabolic effects (weight gain, glucose dysregulation)

Adding Atomoxetine:

• Atomoxetine is a norepinephrine reuptake inhibitor that can be combined with other psychotropic medications 6
• The FDA label warns about cardiovascular effects and suicidality but does not contraindicate use with other antidepressants 3
• Monitor blood pressure carefully as both atomoxetine and bupropion can increase it

Clinical Algorithm for Safe Prescribing

Before Initiating This Combination:

1. Cardiovascular assessment: Measure baseline blood pressure and heart rate; avoid if uncontrolled hypertension present
2. Seizure history: Document any history of seizures or risk factors (head trauma, alcohol withdrawal, eating disorders)
3. Psychiatric evaluation: Screen for active suicidal ideation, particularly in patients under 25 years old
4. Medication reconciliation: Confirm no concurrent MAOI use (14-day washout required) or chronic opioid therapy (contraindicated with naltrexone)

Monitoring Schedule:

First 12 weeks (critical period):

• Blood pressure and heart rate: Weekly for first 4 weeks, then every 2 weeks 7, 2
• Suicidality assessment: Weekly for first month, then biweekly 3
• Seizure precautions: Educate patient on warning signs

Ongoing monitoring:

• Blood pressure/heart rate: Monthly once stable
• Mental status: Each visit for mood changes, agitation, or unusual behavior
• Weight and metabolic parameters if using for obesity treatment

Common Pitfalls to Avoid

Do not combine if:

• Patient has uncontrolled hypertension (systolic >140 or diastolic >90 mmHg)
• History of seizure disorder or eating disorder (bulimia/anorexia)
• Current or recent (within 14 days) MAOI use
• Requires chronic opioid therapy (naltrexone will block opioid effects)
• Patient under 18 years old (limited safety data for this combination) 2

Dose adjustments needed for:

• Renal impairment: Reduce naltrexone/bupropion to 1 tablet twice daily if moderate-severe renal dysfunction 2
• Hepatic impairment: Maximum 1 tablet daily of naltrexone/bupropion if moderate-severe hepatic impairment 2
• Elderly patients (>65 years): Increased sensitivity to CNS effects; start low, go slow 2

Evidence Quality Note

The evidence for this specific four-drug combination is limited. However, guidelines support the use of naltrexone/bupropion together 2, 7, and clinical practice parameters acknowledge that medication combinations are commonly used when treating multiple disorders or when adding medications from different classes 8. The key is having a clear rationale for each medication and a structured monitoring plan 8.

The combination is feasible but requires vigilant monitoring of cardiovascular parameters, CNS effects, and psychiatric symptoms, with clear documentation of the clinical rationale for each medication.